周洁

[摘要] 目的 评价在肺结核合并糖尿病患者治疗中予以血糖控制的临床治疗效果。 方法 该院收治的82例肺结核合并糖尿病患者为该研究选择的样本病例,样本病例选择时段为2013年8月—2015年8月区间,所有患者均予以抗结核治疗9~12个月,并予以血糖控制,以血糖控制情况为依据进行分组,即血糖控制良好45例设置为实验组,而血糖控制差37例患者设置为对照组,治疗后对2组患者临床治疗效果进行比对和评价。结果 相比对于对照组,实验组患者的临床治疗总有效率得以明显提升,同时其他各项指标均明显较优,差异有统计学意义(P<0.05)。 结论 肺结核合并糖尿病患者在治疗中要严格控制血糖水平,血糖得到有效控制,才能提升抗结核治疗的效果。
[关键词] 肺结核;糖尿病;血糖控制;治疗效果
[中图分类号] R521 [文献标识码] A [文章编号] 1672-4062(2017)04(a)-0062-02
[Abstract] Objective To evaluate the clinical effect of blood glucose control in treatment of patients with pulmonary tuberculosis and diabetes. Methods 82 cases of patients with pulmonary tuberculosis and diabetes admitted and treated in our hospital from August 2013 to August 2015 were selected and were given the anti-tuberculosis treatment for 9-12 months, and blood glucose control and the patients were divided into two groups according to the blood glucose control situation, the experimental group with 45 cases were the patients whose blood glucose was good, while the control group with 37 cases were the patients whose blood glucose was bad, after treatment, the clinical treatment effect was compared and evaluated. Results The total clinical effective rate in the experimental group obviously increased compared with that in the control group, and the other indexes were obviously better, and the differences between the two groups were statistically significant(P<0.05). Conclusion The patients with pulmonary tuberculosis and diabetes should strictly the blood glucose level in treatment thus effectively controlling the blood glucose and improving the anti-tuberculosis effect.
[Key words] Pulmonary tuberculosis; Diabetes; Blood glucose control; Treatment effect
糖尿病作為一种发病率较高的慢性疾病,其发病率在近些年来呈现逐渐增长的趋势,糖尿病患者由于会降低其免疫功能,也会导致机体代谢障碍,因此,很容易发生肺结核[1]。2种疾病会互相影响,加重病情,同时治疗难度也得以明显增加,因此,对患者血糖进行有效控制至关重要。该研究选取于2013年8月—2015年8月间该院收治的82例肺结核合并糖尿病患者,对在治疗中血糖控制对治疗效果的影响作用进行进一步评价,现报道如下。
1 资料与方法
1.1 一般资料
该院收治的82例肺结核合并糖尿病患者为该研究选择的样本病例,其中包括49例男性患者和33例女性患者,患者中72岁为最大年龄,22岁为最小年龄,中位年龄为(47.15±9.12)岁,糖尿病最长病程为7年,最小病程为1年,中位病程为(2.65±0.35)年;……